Cargando…
Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis
INTRODUCTION: The emerging epidemiological evidence of increased cardiovascular disease (CVD) risk among persons diagnosed with tuberculosis (TB) has not been systematically reviewed to date. Our aim was to review the existing epidemiological evidence for elevated risk of CVD morbidity and mortality...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351210/ https://www.ncbi.nlm.nih.gov/pubmed/32649721 http://dx.doi.org/10.1371/journal.pone.0235821 |
_version_ | 1783557407237996544 |
---|---|
author | Basham, Christopher Andrew Smith, Sarah J. Romanowski, Kamila Johnston, James C. |
author_facet | Basham, Christopher Andrew Smith, Sarah J. Romanowski, Kamila Johnston, James C. |
author_sort | Basham, Christopher Andrew |
collection | PubMed |
description | INTRODUCTION: The emerging epidemiological evidence of increased cardiovascular disease (CVD) risk among persons diagnosed with tuberculosis (TB) has not been systematically reviewed to date. Our aim was to review the existing epidemiological evidence for elevated risk of CVD morbidity and mortality among persons diagnosed with TB compared to controls. MATERIALS AND METHODS: EMBASE, MEDLINE, and Cochrane databases were searched (inception to January 2020) for terms related to “tuberculosis” and “cardiovascular diseases”. Inclusion criteria: trial, cohort, or case-control study design; patient population included persons diagnosed with TB infection or disease; relative risk (RR) estimate and confidence interval reported for CVD morbidity or mortality compared to suitable controls. Exclusion criteria: no TB or CVD outcome definition; duplicate study; non-English abstract; non-human participants. Two reviewers screened studies, applied ROBINS-I tool to assess risk of bias, and extracted data independently. Random effects meta-analysis estimated a pooled RR of CVD morbidity and mortality for persons diagnosed with TB compared to controls. RESULTS: 6,042 articles were identified, 244 full texts were reviewed, and 16 were included, meta-analyzing subsets of 8 studies’ RR estimates. We estimated a pooled RR of 1.51 (95% CI: 1.16–1.97) for major adverse cardiac events among those diagnosed with TB compared to non-TB controls (p = 0.0024). A ‘serious’ pooled risk of bias was found across studies with between-study heterogeneity (I2 = 75.3%). CONCLUSIONS: TB appears to be a marker for increased CVD risk; however, the literature is limited and is accompanied by serious risk of confounding bias and evidence of publication bias. Further retrospective and prospective studies are needed. Pending this evidence, best practice may be to consider persons diagnosed with TB at higher risk of CVD as a precautionary measure. |
format | Online Article Text |
id | pubmed-7351210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-73512102020-07-22 Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis Basham, Christopher Andrew Smith, Sarah J. Romanowski, Kamila Johnston, James C. PLoS One Research Article INTRODUCTION: The emerging epidemiological evidence of increased cardiovascular disease (CVD) risk among persons diagnosed with tuberculosis (TB) has not been systematically reviewed to date. Our aim was to review the existing epidemiological evidence for elevated risk of CVD morbidity and mortality among persons diagnosed with TB compared to controls. MATERIALS AND METHODS: EMBASE, MEDLINE, and Cochrane databases were searched (inception to January 2020) for terms related to “tuberculosis” and “cardiovascular diseases”. Inclusion criteria: trial, cohort, or case-control study design; patient population included persons diagnosed with TB infection or disease; relative risk (RR) estimate and confidence interval reported for CVD morbidity or mortality compared to suitable controls. Exclusion criteria: no TB or CVD outcome definition; duplicate study; non-English abstract; non-human participants. Two reviewers screened studies, applied ROBINS-I tool to assess risk of bias, and extracted data independently. Random effects meta-analysis estimated a pooled RR of CVD morbidity and mortality for persons diagnosed with TB compared to controls. RESULTS: 6,042 articles were identified, 244 full texts were reviewed, and 16 were included, meta-analyzing subsets of 8 studies’ RR estimates. We estimated a pooled RR of 1.51 (95% CI: 1.16–1.97) for major adverse cardiac events among those diagnosed with TB compared to non-TB controls (p = 0.0024). A ‘serious’ pooled risk of bias was found across studies with between-study heterogeneity (I2 = 75.3%). CONCLUSIONS: TB appears to be a marker for increased CVD risk; however, the literature is limited and is accompanied by serious risk of confounding bias and evidence of publication bias. Further retrospective and prospective studies are needed. Pending this evidence, best practice may be to consider persons diagnosed with TB at higher risk of CVD as a precautionary measure. Public Library of Science 2020-07-10 /pmc/articles/PMC7351210/ /pubmed/32649721 http://dx.doi.org/10.1371/journal.pone.0235821 Text en © 2020 Basham et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Basham, Christopher Andrew Smith, Sarah J. Romanowski, Kamila Johnston, James C. Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis |
title | Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis |
title_full | Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis |
title_fullStr | Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis |
title_full_unstemmed | Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis |
title_short | Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis |
title_sort | cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351210/ https://www.ncbi.nlm.nih.gov/pubmed/32649721 http://dx.doi.org/10.1371/journal.pone.0235821 |
work_keys_str_mv | AT bashamchristopherandrew cardiovascularmorbidityandmortalityamongpersonsdiagnosedwithtuberculosisasystematicreviewandmetaanalysis AT smithsarahj cardiovascularmorbidityandmortalityamongpersonsdiagnosedwithtuberculosisasystematicreviewandmetaanalysis AT romanowskikamila cardiovascularmorbidityandmortalityamongpersonsdiagnosedwithtuberculosisasystematicreviewandmetaanalysis AT johnstonjamesc cardiovascularmorbidityandmortalityamongpersonsdiagnosedwithtuberculosisasystematicreviewandmetaanalysis |